$Novo Nordisk AS(NVO.US)【Has been repurchasing shares continuously, with 5.9 billion repurchased so far, only one-third of the plan】

Novo Nordisk plans to repurchase B shares for up to DKK 15 billion within the 12-month period starting from February 4, 2026. As of June 26, 2026, since February 4, 2026, Novo Nordisk has repurchased a total of 22,009,179 B shares at an average price of DKK 268.02 per B share, with a transaction value of DKK 5,898,848,910.

The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.